TP53 and invasive carcinoma: In addition, there is a progressive increase in p53 positivity from dysplastic lesions to carcinoma in situ and invasive carcinoma [23, 66, 69], and a high correlation between protein overexpression and the presence of TP53 mutations [20, 21].